Given that finerenone was beneficial in patients already receiving an SGLT2 inhibitor, our findings point to finerenone as a new second pillar in HFmrEF/HFpEF. Approved in 2021 based on data from the FIDELIO-DKD and FIGARO-DKD trials, Bayer announced on August 05, 2024 the FINEARTS-HF trial had met its primary endpoint
Semaglutida (Wegovy) para el manejo de peso: anlisis clnico 2026 Actualizado: 07 de enero de 2026 DESCARGO DE RESPONSABILIDAD MDICA: Este artculo es una revisin informativa sobre farmacologa clnica
To prevent low blood sugar, always keep a low-calorie sugary snack or drink on you to take if you feel your blood sugar drop
None of the treatment-emergent substitutions listed above in Mpro or Mpro cleavage sites occurred in PAXLOVID-treated subjects who experienced hospitalization
Pharmaceutical-grade injectable products are manufactured under ISO Class 5 (Class 100) cleanroom conditions using laminar flow hoods that maintain unidirectional HEPA-filtered air across the work surface
The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology